New clinical trials on memory loss interventions are currently enrolling healthy participants with key Alzhemier’s biomarkers as young as 55 years old. Tau and…
Despite the absence of disease-modifying treatments, the dementia rate in developed Western countries has actually declined in recent years. In fact, one study showed…
You may have read about it in the New York Post: “Scientists pinpoint personality traits that increase risk of Alzheimer’s.” A recent study published in…
The amyloid hypothesis—the idea that Alzheimer’s is caused by clumps of proteins known as beta-amyloid—remains unproven. But scientists are holding out hope that monoclonal…
The biotechnology company Eisai Co., Ltd. announced a rolling submission for accelerated approval from the Food and Drug Administration for their anti-amyloid Alzheimer’s treatment,…
Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Professor Nancy Ip Yuk-Yu and her team have developed a blood…
Researchers share insights on the infectious theory of Alzheimer’s—the idea viruses and bacteria may cause Alzheimer’s. Clinical trials are underway to test this theory….
Nikki Schultek, founder of the global medical research consortium Intracell Research Group, takes a close look at how the COVID-19 pandemic may prompt a…
Bad news arrived recently for the constantly caffeinated: Researchers recently found evidence that drinking more than six cups of coffee a day could shrink…
IMAGE: Photobiomodulation tabletop device Beacon40 by neurotechnology company Bright Could flickering lights have brain health benefits? Research around experimental therapies involving external stimuli —…
A recent cell study shows that experimental Parkinson’s and Alzheimer’s antibodies may trigger harmful brain inflammation—which could explain clinical trials’ dismal failure rates. In…
A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well…
Scientists in the field of Alzheimer’s have struggled to carry promising findings in mice studies into human trials, but primate researchers believe that animals…
From the nature of Alzheimer’s to the solutions available for controlling it, here are five common misconceptions to dispel. Alzheimer’s is the sixth leading…